Konferenzen  >  Medizin & Gesundheitswesen  >  Translationale Medizin, Klinische Studien  >  Deutschland

Allan Lloyds

The 12th Annual Risk Management and Pharmacovigilance Summit will take place in Berlin on 6–7 May 2026 and will bring together senior leaders from the pharmaceutical and biotechnology industries to discuss key challenges and innovations in drug safety and pharmacovigilance. The event will explore topics such as AI-powered signal detection, regulatory developments, risk management plans, data integrity, and the integration of real-world evidence into pharmacovigilance systems, providing practical insights and networking opportunities for professionals involved in drug safety, regulatory affairs, and patient safety.

Marketing Manager;     Tel.: [+421 2 21 021 348];     Email: vladyslava.malenta@alloydsevents.com

pharmacovigilance, drug safety, risk management, regulatory affairs, clinical safety, signal detection, benefit-risk assessment, patient safety, pharmaceutical industry, pharmacovigilance systems

Öffentliche Vorträge und Öffentlichkeitsarbeit,    Pharmakogenomik, Personalisierte Medizin

Kenes Exhibitions

Join us for the 3rd RNA Horizons Conference, taking place September 16–18, 2026, in Munich, Germany. This premier event brings together scientists, clinicians, and biotech innovators to explore the latest advancements in RNA therapeutics, spanning established modalities as well as emerging areas such as ASOs and RNA structure–based therapies. Discussions will cover key trends, including pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will focus on translating discoveries into viable therapies, with insights into commercialization and market access.

Tel.: [972 747457435];     Email: skrein@kenes-exhibitions.com

RNA therapeutics, RNA biology, RNA medicine, RNA delivery, antisense oligonucleotides, self-amplifying RNA, RNA-based therapy, cancer research, oncology innovation, RNA stability, clinical translation, biotechnology, life sciences, European biotech, Horizon Europe, CANCERNA consortium, Hadassah Cancer Research Institute, RNA Horizons, RNA conference Europe, Munich 2026, RNA innovation, European research collaboration

Biotechnologie,    Pharmakologie und Arzneimittelentwicklung